Discovery of 5-substituent-N-arylbenzamide derivatives as potent, selective and orally bioavailable LRRK2 inhibitors. [electronic resource]
Producer: 20170908Description: 4034-4038 p. digitalISSN:- 1464-3405
- Administration, Oral
- Benzamides -- administration & dosage
- Dose-Response Relationship, Drug
- Drug Discovery
- Humans
- Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 -- antagonists & inhibitors
- Molecular Structure
- Protein Kinase Inhibitors -- administration & dosage
- Structure-Activity Relationship
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.